San Diego, California
Booth: 3346
We’re excited to announce our attendance at SLAS 2025! This event is all about advancing life sciences through technology and collaboration, making it the perfect venue for Ncardia’s cutting-edge stem cell-based screening and assay solutions. Join us to explore how our innovations are powering precision and speed in drug discovery and development. Let’s connect to discuss how we can partner to accelerate therapeutic breakthroughs.
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.
Let's chat at SLAS 2025!